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Retinoma is the benign precursor to the childhood eye 
tumor, retinoblastoma. In rare cases, it remains benign 
for the lifetime of the individual, never progressing to 
retinoblastoma. Retinoma has three (3) characteristic 
clinical features: a grey, translucent mass in the retina; 
cottage cheese-like calcification; and a hyperplastic 
retinal epithelium/chorioretinal scar (Gallie et al., 
1982). Vitreous seeds have also been observed 
associated with retinoma (Lueder et al., 1995). 
 
Clinics and pathology 
Note 
The diagnosis of retinoma is made by clinical 
observation. Evidence of retinoma in eyes removed for 
retinoblastoma is often observed by histology (Dimaras 
et al., 2008; Eagle, 2009), and sometimes clinically 
after treatment of the overlying retinoblastoma tumor 
(Dimaras et al., 2009). 
Epidemiology 
Retinoma has been observed clinically in 1.8% (Gallie 
et al., 1982) to 3.2% (Abouzeid et al., 2012) of 
retinoblastoma cases and by pathology in 15.6% 
(Dimaras et al., 2008) to 20.4% (Eagle, 2009) of 
enucleated retinoblastoma specimens. 
 
Retinoma showing classic features of chorioretinal scar, translucent retinal mass and calcification.  
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Retinoma histology showing abundant fleurettes and sparse cells with eosinophilic cytoplasm. 
 
Pathology 
Retinoma is histologically distinct from its malignant 
counterpart, retinoblastoma.  
Retinoma displays abundant fleurettes, eosinophilic 
cytoplasm, foci of calcification and non-proliferative 
cells (Margo et al., 1983; Dimaras et al., 2008).  
Retinoma lacks the typical features of retinoblastoma 
(Homer Wright and Flexner-Wintersteiner rosettes, 
nuclear molding, abundant mitoses and necroses), and 
is often observed adjacent to retinoblastoma tumor in 
enucleated specimens (Dimaras et al., 2008). 
Treatment 
Frequent ophthalmic examination monitors for 
potential malignant progression. Malignant progression 
is more common in children with retinoma than in 
adults. In a child, the physician may opt to treat 
retinoma as retinoblastoma if there is even a minor 
suspicion of malignant progression. 
Evolution 
Because retinomas share the same genetic origin as 
retinoblastoma and are frequently observed adjacent to 
retinoblastoma in pathological specimens, it is 
hypothesized that every retinoblastoma passes through 
a retinoma stage. However, rare retinomas do not ever 
progress to retinoblastoma. The difference between the 
retinomas that progress to malignancy and those that do 
not is unknown. Benign cystic growth has also been 
observed in some retinomas (Sampieri et al., 2008; 
Abouzeid et al., 2012). 
Prognosis 
Retinoma is by definition benign and does not pose any 
threat to life, thought it may interfere with vision.  
Regular examination of rare individuals with retinoma 
is necessary to spot any sign of malignant 
transformation to retinoblastoma. 
Cytogenetics 
Note 
Retinomas identified histologically adjacent to 
retinoblastomas have been studied by FISH. Retinomas 
display low level genomic copy number changes in 
several genes altered to a higher degree in adjacent 
retinoblastoma tumors (Gain: KIF14, DEK, E2F3, 
MYCN; Loss: CDH11), suggesting a shared origin 
(Dimaras et al., 2008).  
The altered copy number changes in retinoma are not 
manifested at the expression level as in retinoblastoma. 
Genes involved and proteins 
Note 
Like retinoblastoma, retinoma is initiated by the loss of 
both copies of the RB1 tumor suppressor gene. 
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Note 
Retinoma is initiated by the loss of both copies of the 
RB1 gene.  
Adjacent specimens of retinoblastoma and retinoma 
display the same mutation(s) in RB1 (Dimaras et al., 
2008). 
DNA / RNA 
DNA: 27 exons, 180 kb genomic DNA; RNA: 4840 bp 
mRNA transcript. 
Protein 





Retinoma is marked by upregulation of p16INK4A 
mRNA and protein, which is not observed in 
retinoblastoma.  
The upregulation of the senescence-associated protein 
may account for the non-proliferative nature of 
retinoma (Dimaras et al., 2008). 
DNA / RNA 
DNA: 3 exons, 6.6 kb genomic DNA; RNA: 471 bp 
mRNA transcript. 
Protein 
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